Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overnight variation in tidal expiratory flow limitation in COPD patients and its correction: an observational study.

Respiratory research·2021
Same author

Meeting the GOLD Standard: COPD Treatment in the UK Today.

EClinicalMedicine·2019
Same author

Scientific Business Abstracts of the 113th Annual Meeting of the Association of Physicians of Great Britain and Ireland.

QJM : monthly journal of the Association of Physicians·2019
Same author

Human rhinovirus-induced inflammatory responses are inhibited by phosphatidylserine containing liposomes.

Mucosal immunology·2017
Same author

Hypoxia determines survival outcomes of bacterial infection through HIF-1alpha dependent re-programming of leukocyte metabolism.

Science immunology·2017
Same author

The effect of neoadjuvant chemotherapy and chemoradiotherapy on exercise capacity and outcome following upper gastrointestinal cancer surgery: an observational cohort study.

BMC cancer·2016

Related Experiment Videos

Pathological networking: a new approach to understanding COPD.

I Sabroe1, L C Parker, P M A Calverley

  • 1Academic Unit of Respiratory Medicine, Section of Infection, Inflammation and Immunity, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK. i.sabroe@sheffield.ac.uk

Postgraduate Medical Journal
|May 30, 2008
PubMed
Summary
This summary is machine-generated.

Developing effective treatments for chronic obstructive pulmonary disease (COPD) is difficult due to irreversible tissue damage. This review explores COPD as an immune network, suggesting new therapeutic strategies for this chronic respiratory disease.

Related Experiment Videos

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Pathophysiology

Background:

  • Chronic obstructive pulmonary disease (COPD) presents a significant therapeutic challenge due to irreversible tissue damage and disease progression.
  • Current treatment strategies face difficulties in influencing the stable disease state or reversing its effects.

Purpose of the Study:

  • To examine the nature of COPD as a complex pathological network.
  • To propose refined strategies for developing effective treatments for COPD.

Main Methods:

  • Conceptual review of COPD pathophysiology.
  • Utilizing simple tissue models of inflammation.
  • Analysis of COPD as a disease network with contiguous immunity.

Main Results:

  • COPD involves a complex network of immune processes (innate and adaptive immunity).
  • This network exhibits features of contiguous immunity, with ongoing dialogue and evolution.
  • Understanding this network is key to identifying therapeutic targets.

Conclusions:

  • Refined treatment strategies for COPD should consider its nature as an immune network.
  • Targeting key components within this pathological network may yield substantial clinical benefits.
  • Further research into the immune dynamics of COPD is warranted for novel therapeutic development.